Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Editorial

Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?

Heejoon Jang, Won Kim

Clin Mol Hepatol. 2023;29(2):381-383. Published online March 9, 2023

DOI: https://doi.org/10.3350/cmh.2023.0088

View: 4322 Download: 98 Web of Science: 4 Crossref: 4

Review

Radiomics and radiogenomics of primary liver cancers

Woo Kyoung Jeong, Neema Jamshidi, Ely Richard Felker, Steven Satish Raman, David Shinkuo Lu

Clin Mol Hepatol. 2019;25(1):21-29. Published online November 16, 2018

DOI: https://doi.org/10.3350/cmh.2018.1007

View: 14329 Download: 434 Web of Science: 51 Crossref: 54

The mutational landscape of hepatocellular carcinoma

Ju-Seog Lee

Clin Mol Hepatol. 2015;21(3):220-229. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.220

View: 15785 Download: 399 Web of Science: 99 Crossref: 91

Original Article

Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target

Gu-Wei Ji, Zheng-Gang Xu, Shuo-Chen Liu, Shu-Ya Cao, Chen-Yu Jiao, Ming Lu, Biao Zhang, Yue Yang, Qing Xu, Xiao-Feng Wu, Ke Wang, Yong-Xiang Xia, Xiang-Cheng Li, Xue-Hao Wang

Received October 9, 2024 Accepted February 7, 2025

DOI: https://doi.org/10.3350/cmh.2024.0895 [Accepted]

View: 6916 Download: 291

Molecular Classification of Hepatocellular Carcinoma based on Zoned Metabolic Feature and Oncogenic Signaling Pathway

Tomoko Aoki, Naoshi Nishida, Yutaka Kurebayashi, Kazuko Sakai, Naoto Fujiwara, Masakatsu Tsurusaki, Kohei Hanaoka, Masahiro Morita, Hirokazu Chishina, Masahiro Takita, Satoru Hagiwara, Hiroshi Ida, Kazuomi Ueshima, Yasunori Minami, Atsushi Takebe, Takaaki Murase, Keiko Kamei, Takuya Nakai, Ippei Matsumoto, Kazuto Nishio, Masatoshi Kudo

Received December 3, 2024 Accepted March 7, 2025

DOI: https://doi.org/10.3350/cmh.2024.1088 [Accepted]

View: 1491 Download: 180

Review

Prospects of Mendelian Randomization in Hepatology: A Comprehensive Literature Review with Practice Guidance Mendelian randomization and hepatology

Lanlan Chen, Qi Rao, Menghan Gao, Guoyue Lv, Frank Tacke

Received May 16, 2025 Accepted June 3, 2025

DOI: https://doi.org/10.3350/cmh.2025.0541 [Accepted]

View: 309 Download: 36

1 |

Viewed By 11441	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7184	MAFLD: How is it different from NAFLD?
Viewed By 5477	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Viewed By 5134	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4579	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma

Cited By 349	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 328	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 219	MAFLD: How is it different from NAFLD?
Cited By 113	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 110	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search